Camber Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-441,000	Closed	-$17.2M	–	29
2025 Q1	$17.2M	Hold	441,000	–	–	0.61%	20
2024 Q4	$23.9M	Hold	441,000	–	–	0.55%	25
2024 Q3	$22.2M	Buy	441,000 +86,000	+24%	+$4.34M	0.71%	24
2024 Q2	$15.6M	Buy	+355,000	New	+$15.6M	0.43%	28